Apostolos Perelas is a Respiratory physician affiliated with Virginia Commonwealth University. OpenAlex indexes 66 publications with 1,291 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9000 Stony Point Pkwy
Richmond, VA 232351900
Telephone
804-560-8920Registry record last updated 30 Sept 2019.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202512 payments$11,594openpaymentsdata.cms.gov ↗
- United Therapeutics CorporationProgram year20255 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
26.3%Corticosteroid10.6%Prednisone100%Part D≥89 patientsProton pump inhibitor8.8%Pantoprazole Sodium61%Omeprazole39%Part D≥32 patients+ 6 more classes in this area
Respiratory
20.8%Corticosteroid12.3%Fluticasone Propionate41%Trelegy Ellipta27%Budesonide-Formoterol Fumarate7%Breyna7%Symbicort7%Arnuity Ellipta6%Breo Ellipta5%Part D<11 patientsLeukotriene Receptor Antagonist4%Montelukast Sodium100%Part D≥22 patients+ 2 more classes in this area
Cancer & immunology
20.2%Kinase inhibitor9.6%Ofev100%Part D≥38 patientsPyridone8.6%Pirfenidone100%Part D≥40 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Piezo2 Is a Key Mechanoreceptor in Lung Fibrosis that Drives Myofibroblast Differentiation
American Journal Of Pathology
2025 - Pulmonary Fibrosis—Focusing on the Future: Aspen Lung Conference 2024 Summary
American Journal of Respiratory Cell and Molecular Biology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Jasmohan Bajaj, MD
Virginia Commonwealth University
Patrick Ching, MD, MPH
Virginia Commonwealth University
Bruce Rubin, MD
Virginia Commonwealth University
Arehzo Jahangiri, MD
Virginia Commonwealth University
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”